TG Therapeutics (TGTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the s ...

United Fire Group (UFCS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on Augus ...

Zacks Consensus Estimate This discount airline is expected to post quarterly loss of $0.28 per share in its upcoming report, which represents a year-over-year change of -300%. Revenues are expected to be $933.63 million, down 4.1% from the year-ago quarter. Estimate Revisions Trend The consensus EPS estimate for the quarter has been revised 229.07% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estima ...

核心观点 - 市场预期Toast在截至2025年6月的季度财报中营收和盈利将实现同比增长 实际业绩与预期的对比可能影响短期股价[1][2] - 公司盈利预期存在上修迹象但Zacks评级较低 难以明确预测其能否超预期[12] - 历史数据显示公司过去四个季度中有三次盈利超预期[13][14] 财务预期 - 预计季度每股收益为0.24美元 同比增长1100%[3] - 预计季度营收为15.3亿美元 同比增长23.4%[3] - 最准确预估高于共识预期 形成+1.70%的盈利ESP[12] 预期修订情况 - 过去30天内季度EPS共识预期保持未变[4] - 分析师在财报发布前的最新修订可能包含更准确信息[8] - 盈利ESP正偏差理论上预示实际盈利可能超预期[9] 历史表现 - 上一季度实际EPS为0.20美元 超预期5.26%[13] - 过去四个季度中三次击败EPS共识预期[14] 影响因素 - 管理层在财报电话会议中对业务状况的讨论将影响股价可持续性[2] - 正盈利ESP结合Zacks排名前三级别可提高预测准确率至近70%[10] - 负盈利ESP或低Zacks排名难以 confident 预测盈利超预期[11]

核心财务预期 - 预计季度每股收益2.09美元 同比下跌7.9% [3] - 预计季度营收2.982亿美元 同比下跌8% [3] - 过去30天共识每股收益预期下调1.9%至当前水平 [4] 业绩预测指标 - 盈利预期差异(ESP)为-0.08% 显示分析师近期转向悲观 [12] - Zacks评级为第3级(持有) [12] - 负值ESP与第3级评级组合难以预测超越预期 [12] 历史业绩表现 - 上季度实际每股收益2.15美元 超越预期1.59美元达35.22% [13] - 过去四个季度均超越共识每股收益预期 [14] 同业比较 - 林肯国民(LNC)预计季度每股收益1.91美元 同比增长3.8% [18] - 林肯国民预计季度营收46.7亿美元 同比增长3.1% [18] - 林肯国民盈利预期差异(ESP)为-0.73% Zacks评级同为第3级 [19]

Select Water Solutions, Inc. (WTTR) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on August 5, might help the stock move higher if these key numbers ...

Upstart Holdings, Inc. (UPST) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on ...

核心观点 - 华尔街预期Evolus在2025年第二季度营收增长但每股亏损同比恶化 实际业绩与预期对比可能影响短期股价[1][2] - Zacks预期每股亏损0.09美元(同比恶化28.6%) 营收8293万美元(同比增长23.9%)[3] - 盈利预期修正趋势显示过去30天共识EPS预估未变 但分析师个体修正方向可能不同[4] - 盈利超预期预测模型显示Evolus的ESP为-28.57%且Zacks评级为3 难以确信其会超越预期[11] - 公司过去四个季度均未达到EPS预期 最近一季实际亏损0.18美元较预期0.1美元差80%[12][13] - 同业公司ResMed预计每股盈利2.46美元(同比增长18.3%) 营收13.2亿美元(增长8.2%) ESP为+5.16%且连续四季超预期[17][18] 财务预期 - 季度共识EPS预估为亏损0.09美元 较去年同期恶化28.6%[3] - 季度营收预期8293万美元 较去年同期增长23.9%[3] - 过去30天共识EPS预估保持稳定 未出现修正[4] 业绩预测模型 - Zacks盈利ESP模型通过对比最准确预估与共识预估来预测偏差[6][7] - 正ESP读数结合Zacks评级1-3级可提高预测效力 组合策略成功率近70%[8][9] - Evolus最准确预估低于共识预估 ESP读数为-28.57% Zacks评级为3级[11] - 负ESP读数不具备盈利不及预期的指示性 但会降低预测置信度[10] 历史表现 - 最近报告季度实际每股亏损0.18美元 较预期0.1美元差异-80%[12] - 连续四个季度未能达到共识EPS预期[13] 同业对比 - 同业ResMed预计季度EPS为2.46美元(同比增长18.3%) 营收13.2亿美元(增长8.2%)[17] - ResMed过去30天共识EPS预估上调0.5% ESP读数为+5.16% Zacks评级为3级[18] - ResMed过去四个季度均超越EPS预期[18]

CryoPort, Inc. (CYRX) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on August 5. ...

核心财务预期 - EVgo公司预计在2025年6月季度每股亏损0.10美元 与去年同期持平 营收预计为8736万美元 同比增长31.1% [1][3] - 博格华纳公司预计同期每股收益1.06美元 同比下降10.9% 营收预计35.6亿美元 同比下降1.3% [18][19] 盈利预测修正趋势 - EVgo的共识每股收益预期在过去30天内下调2.38% 反映分析师集体重新评估初始预测 [4] - 博格华纳共识每股收益预期在过去30天内上调1.3% 且更高精确定值导致盈利ESP达到+7% [19] 盈利超预期预测指标 - EVgo最精确估计低于共识预期 盈利ESP为-30.00% 结合Zacks评级第3级 难以预测其将超越共识每股收益预期 [12] - 博格华纳盈利ESP为+7% 结合Zacks评级第3级 显示很可能超越共识每股收益预期 [20] 历史盈利表现 - EVgo在上个报告季度实际每股亏损0.09美元 优于预期的0.11美元 实现+18.18%的正向意外 [13] - EVgo在过去四个季度中有三次超越共识每股收益预期 [14] - 博格华纳在过往四个季度中每次均超越共识每股收益预期 [20] 行业比较与市场影响 - 实际业绩与预期比较可能影响EVgo短期股价 优于预期可能推高股价 低于预期可能导致下跌 [2] - 博格华纳作为汽车原设备行业代表 显示行业内部企业表现分化 [18]